These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3373745)

  • 41. A combination of pirenzepine and cimetidine: a new approach to treatment of duodenal ulcer in "non-responders".
    Dal Monte PR; D'Imperio M; Ferri M; Fratucello F; del Soldato P
    Hepatogastroenterology; 1985 Jun; 32(3):126-8. PubMed ID: 3839484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Drug therapy of peptic ulcers].
    Fukutomi H; Nakahara A
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):47-54. PubMed ID: 1673704
    [No Abstract]   [Full Text] [Related]  

  • 43. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug therapy of peptic ulcer. What is coming up?].
    Müller P; Dammann HG; Simon B; Kommerell B
    Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Long-term therapy of peptic ulcer disease].
    Müller P; Dammann HG; Simon B
    MMW Munch Med Wochenschr; 1982 Nov; 124(44):971-2. PubMed ID: 6296668
    [No Abstract]   [Full Text] [Related]  

  • 46. Relapse of Helicobacter pylori infection after different treatment regimens. A 3-month follow-up study.
    Nanivadekar SA; Sawant PD; Patel HD; Shroff CP; Popat UR; Bhatt PP
    J Assoc Physicians India; 1990 Sep; 38 Suppl 1():712-5. PubMed ID: 2092026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The drug prophylaxis of peptic ulcer exacerbations].
    Grigor'ev PIa; Iakovenko EP; Agafonova NA; Prianishnikova AS; Soluianova IP; Iakovenko AV; Vasil'ev IV; Agrba VZ; Stepanov AV; Kolodkin AM
    Ter Arkh; 1995; 67(2):26-9. PubMed ID: 7725253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine.
    Libeskind M
    Scand J Gastroenterol Suppl; 1983; 83():69-70. PubMed ID: 6356324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acid suppression with ranitidine plus oral triple therapy improves ulcer healing but not Helicobacter pylori eradication.
    Magalhaes AF; Macedo C; Hauck JR; Carvalhaes A; De Nucci G; Magna LA; Pedrazzoli J
    Hepatogastroenterology; 1998; 45(24):2161-4. PubMed ID: 9951885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association of ranitidine and sucralfate in the short-term treatment of duodenal ulcers, as compared to other forms of treatment.
    Magnanelli M; Belvisi A; Toninelli A; Matergi M; Camarri E
    Int J Tissue React; 1984; 6(2):189-93. PubMed ID: 6329980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
    Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
    [No Abstract]   [Full Text] [Related]  

  • 53. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.
    Tseng GY; Lin HJ; Fang CT; Yang HB; Tseng GC; Wang PC; Hung TL; Deng YC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2007 Sep; 26(6):925-33. PubMed ID: 17767477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S; Newton WP
    J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
    [No Abstract]   [Full Text] [Related]  

  • 55. [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
    Lux G
    Fortschr Med; 1996 Aug; 114(22-23):273-5. PubMed ID: 8974961
    [No Abstract]   [Full Text] [Related]  

  • 56. The clinical use of histamine-2 receptor antagonists.
    Michocki RJ; Richardson JP
    Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Some aspects of the critical evaluation of peptic ulcer therapy in patients.
    Mózsik G; Bertelli A; Deak G; Nagy L; Patty I; Simon L; Tárnok F; Jávor T
    Int J Clin Pharmacol Res; 1985; 5(6):447-55. PubMed ID: 4093220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
    Boixeda de Miquel D
    Rev Esp Enferm Dig; 1997 Dec; 89(12):875-7. PubMed ID: 9494374
    [No Abstract]   [Full Text] [Related]  

  • 59. [Acute therapy of duodenal ulcer. Comparison of famotidine and ranitidine in a single evening dose].
    Kimmig JM
    Fortschr Med; 1987 Feb; 105(5):72-6. PubMed ID: 3549493
    [No Abstract]   [Full Text] [Related]  

  • 60. [Current therapy of Helicobacter pylori-induced chronic gastritis and/or peptic ulcer].
    Hentschel E
    Wien Klin Wochenschr; 1994; 106(17):543-6. PubMed ID: 7975668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.